VTR logo

VTR Ventas, Inc.

New York Stock Exchange · REIT - Healthcare Facilities · Real Estate

$90.79
-0.73 (-0.80%)

As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of …

Market Cap: $44.14Bwww.ventasreit.com

Price

No data yet.

Signal Score (90d)

120
120
Aug 17Aug 17

Revenue

$1.73B+77.20%
$976.08M$1.23B$1.48B$1.73B
Sep 2021Jun 2026

Quote

Day Range
$90.54 – $91.63
52-Week Range
$66.38 – $101.60
Volume
$1.39M
Market Cap
$44.14B
50-Day Avg
$90.17
200-Day Avg
$83.89
Prev Close
$91.52
Open
$91.30

Valuation & Ratios

P/E Ratio
140.69
EPS
$0.55
P/B Ratio
2.81
P/S Ratio
6.04
Debt/Equity
1.06
Current Ratio
0.96
Dividend Yield
+2.4%
Gross Margin
-5.9%

Returns & Efficiency

Return on Equity
+2.0%
Return on Assets
+0.9%
FCF Yield
+3.7%
EV/EBITDA
21.30

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$5.83B$251.38M$0.55
2024$4.92B$81.15M$0.20
2023$4.50B$-40.97M$-0.10
2022$4.13B$-47.45M$-0.13
2021$3.83B$49.01M$0.13

Social Signal Score

70
5d
71
1 mentions
30d
70
1 mentions
60d
70
1 mentions
90d
70
1 mentions
news: 1

Earnings

Wed, Oct 28(in 2 months)

Consensus estimate $0.15 per share

3of 7 quarters beat consensus

Typical surprise -1.6% (median, so one quarter with a near-zero estimate can't distort it)

  • Wed, Jul 29$0.14 vs $0.14miss
  • Mon, Apr 27$0.11 vs $0.12miss
  • Thu, Feb 5$0.15 vs $0.10beat
  • Wed, Oct 29$0.14 vs $0.09beat
  • Wed, Jul 30$0.15 vs $0.85miss
  • Wed, Apr 30$0.11 vs $0.82miss

Estimates and results for VTR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Insider trading

Open-market buys and sells by VTR officers and directors.

Bought
$197k

1 trade

Sold
$4.8m

4 trades

  • Embler Michael Jbought
    director·2,500 @ $78.81·$197k·Jun 3, 2026·filing
  • Rakowich Walter Csold
    director·1,152 @ $90.20·$104k·May 14, 2026·filing
  • Roberts Carey S.sold
    EVP and GC·35,532 @ $85.00·$3.0m·Feb 11, 2026·filing
  • Cafaro Debra Asold
    director, officer: Chairman and CEO·10,322 @ $82.23·$849k·Feb 6, 2026·filing
  • Cafaro Debra Asold
    director, officer: Chairman and CEO·10,322 @ $77.66·$802k·Feb 2, 2026·filing

95 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from VTR's reported EPS growth of 43.4% a year over 4 years. Historical EPS growth of 43% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.

EPS in 5 years
$2.05
Implied price
$36.92
Return from $90.79
-16.5% a year

To earn 15.0% a year on these assumptions you'd need to buy at $18.35 -79.8% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E1215182124
20.0%-28.9%-25.7%-22.9%-20.5%-18.3%
25.0%-25.9%-22.6%-19.7%-17.2%-14.9%
30.0%-23.0%-19.5%-16.5%-13.9%-11.5%
35.0%-20.0%-16.4%-13.3%-10.5%-8.1%
40.0%-17.1%-13.3%-10.0%-7.2%-4.7%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newszacks.com·6h ago·Positive

    Ventas (VTR) Could Be a Great Choice Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?

    View source ↗